PR – Publications – Media - Events

Media

ObsEva legt abgestürzten Hoffnungsträger in chinesische Hände

January 29, 2020

Read more

IVF drug innovation lags, belying procedure’s high tech reputation

July 17, 2019

Read more

Ein Frauenarzt, der lieber Unternehmer ist, als Patientinnen in der Praxis zu behandeln

June 12, 2019

Read more

Interview with ObsEva CEO – Ernest Loumaye in moneycab.com (article in German)

June 12, 2019

Read more

Ernest Loumaye, CEO von ObsEva: «2019 wird ein wichtiges Jahr für ObsEva»

June 12, 2019

Read more

Nolasiban Set to Revolutionise Fertility: Interview in ‘The Times’ with ObsEva CEO, Ernest Loumaye

June 12, 2019

Read more

to follow..

June 12, 2019

Read more

ObsEva in L’Agefi: ObsEva commercialisera elle-même ses produits

June 12, 2019

Read more

Video SIX listing

June 12, 2019

Read more

Interview with ObsEva CEO – Ernest Loumaye in Handelszeitung (article in English)

May 6, 2019

Read more

Are you sure you want to leave ObsEva.com?

We’re sorry to see you go. Choose one of the following actions to stay on the site or leave.

Continue to link

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue

Disclaimer

Note that the following information contains information on investigational medicinal products. These products have not yet been approved for marketing by the European Medicines Agency or the U.S. Food and Drug Administration and are still under development. Further additional investigations may be needed in order for the marketing authorization to be granted, which grant may depend on a variety of factors and is not guaranteed. Click on “return” if you do not wish to receive such information. By clicking on “continue” you acknowledge that you wish to receive scientific information on our investigational products.

Continue